Azza H. Idris

Infectious Disease

55 Fruit St
Boston, MA 02114

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 32 publications

Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge.

Mannosylated nanoparticle immunogens enhance the circumsporozoite protein-specific B cell response and improve protection against sporozoite challenge.

Journal: bioRxiv : the preprint server for biology

Published: May 18, 2026

Overcoming immunogenic gaps in malaria subunit vaccines by broadening CSP regions targeted.

Overcoming immunogenic gaps in malaria subunit vaccines by broadening CSP regions targeted.

Journal: The Journal of experimental medicine

Published: May 07, 2026

Anti-malaria antibody engineering broadens recognition motifs and reveals new homotypic interactions that enhance protective breadth.

Anti-malaria antibody engineering broadens recognition motifs and reveals new homotypic interactions that enhance protective breadth.

Journal: Nature communications

Published: December 01, 2025

Evaluation of microscopy and first response™ malaria Ag PAN/Pf RDT compared to qPCR and hemoglobin levels in pregnant women at delivery in Busia County, Western Kenya.

Evaluation of microscopy and first response™ malaria Ag PAN/Pf RDT compared to qPCR and hemoglobin levels in pregnant women at delivery in Busia County, Western Kenya.

Journal: BMC infectious diseases

Published: November 20, 2025

Anti-Malaria Antibody Engineering Broadens Recognition Motifs and Reveals New Homotypic Interactions that Enhance Protective Breadth.

Anti-Malaria Antibody Engineering Broadens Recognition Motifs and Reveals New Homotypic Interactions that Enhance Protective Breadth.

Journal: bioRxiv : the preprint server for biology

Published: November 19, 2025

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

Journal: NPJ vaccines

Published: October 01, 2025

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

Protective immunity against malaria by a nanoparticle CIS43-based junctional vaccine alone or in combination with R21.

Journal: bioRxiv : the preprint server for biology

Published: September 18, 2025

FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein.

FcγR binding differentially contributes to protection by two human monoclonal antibodies targeting Plasmodium falciparum circumsporozoite protein.

Journal: Science translational medicine

Published: April 23, 2025

Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.

Protective antibodies target cryptic epitope unmasked by cleavage of malaria sporozoite protein.

Journal: Science (New York, N.Y.)

Published: January 02, 2025

Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens.

Elicitation of liver-stage immunity by nanoparticle immunogens displaying P. falciparum CSP-derived antigens.

Journal: NPJ vaccines

Published: September 07, 2024

Pediatric urinary tract infections caused by poultry-associated Escherichia coli.

Pediatric urinary tract infections caused by poultry-associated Escherichia coli.

Journal: Microbiology spectrum

Published: June 12, 2024

Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention.

Monoclonal antibodies to the circumsporozoite proteins as an emerging tool for malaria prevention.

Journal: Nature immunology

Published: May 06, 2024

Showing 1-12 of 32

Last Updated: 09/26/2026